Design of the Beta-Blocker Evaluation Survival Trial (BEST)

This publication has 23 references indexed in Scilit:

• Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
  Journal of the American College of Cardiology, 1994
• Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
  Circulation, 1994
• Usefulness of bucindolol in congestive heart failure
  The American Journal of Cardiology, 1990
• Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
  Circulation, 1990
• Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
  The American Journal of Medicine, 1990
• Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.
  Circulation, 1989
• Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.
  Circulation, 1989
• Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
  Circulation, 1985
• Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.
  Heart, 1980
• Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
  Heart, 1975